- Even though drugs can be a highly effective therapy, most states prohibit psychologists from prescribing medications for their mental health patients.
- Pandemic spending waste: only one quarter of the jobs supported by PPP funds would have disappeared without the program and the funds rarely reached their intended target of rank-and-file workers.
- Paragon report: Medicaid now has more than 15 million ineligible recipients.
- New medical tech claim: a complete genome mapping for$100.
- How that could change medicine.
- Progressive Caucus wants to change the name of Medicare Advantage to curtail its popularity.
Category: Drug Prices & Regulations
Reporter Discovers this “One Weird Trick” to Good Sleep (Why didn’t Doc Tell Him?)
Kaiser Health News reporter Jay Hancock wrote a personal account of his battle to get a good night’s sleep. It all began with a desire for answers: I had been feeling drowsy during the day, and my wife told me I snored. Both can mean obstructive sleep apnea. With obstructive sleep apnea, the mouth and…
Monday Links
- Medicare Advantage enrollees are more likely to get preventive care. Other comparisons with traditional Medicare were mixed.
- GOP’s approach to drug pricing.
- How reliable are blood tests for detecting cancer? (WSJ)
- The case for fasting.
- Even the Biden administration admits, “No one is serving time in federal prison solely for the crime of marijuana possession.” (WSJ)
The $1 Million a Year Drug Club is Growing
On September 30 the U.S. Food and Drug Administration (FDA) approved, Relyvrio, a drug to slow the progression of ALS, also known as Lou Gehrig’s disease. The approval was controversial. The FDA usually requires at least two clinical trials but will on occasion accept one trial if the trial was robust and the data provides persuasive evidence…